我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

主动脉内球囊反搏治疗对晚期扩张型心肌病患者血浆脑钠尿肽的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第6期
页码:
726-728
栏目:
临床研究
出版日期:
2012-12-25

文章信息/Info

Title:
Effect of intra-aortic balloon pump counterpulsation on serum brain natriuretic peptide in patients with terminal dilated cardiomyopathy
作者:
冯春光; 付 强; 王彦炯; 曹秋玫; 阮红云
(徐州市中心医院心内科，江苏 徐州 221009)
Author(s):
FENG Chun-guang;  FU Qiang;  WANG Yan-jiong;  CAO Qiu-mei;  RUAN Hong-yun
(Department of Cardiology, Xuzhou Central Hospital, Xuzhou 221009, Jiangsu, China)
关键词:
心肌病; 扩张型;  主动脉内球囊反搏术;  脑钠尿肽
Keywords:
dilated cardiomyopathy;  intra-aortic balloon pump;  brain natriuretic peptide
分类号:
R542.2
DOI:
-
文献标识码:
A
摘要:
目的:观察主动脉球囊反搏(intra-aortic balloon pump，IABP)治疗在晚期扩张型心肌病（dilated cardiomyopathy，DCM）患者对血浆脑钠尿肽(brain natriuretic peptide，BNP)值变化的影响。方法： 晚期DCM患者41例，在最优药物治疗基础上按是否应用IABP分为IABP植入组（植入组，21例），非植入组（对照组，20例）。免疫化学发光法测患者人院后第1、2、7天血浆BNP浓度。结果： 入院第1天两组BNP值差异无统计学意义。入院后第2、7天，植入组BNP值明显低于对照组 ［(1778±289) ng/L vs. (2553±346) ng/L，P<0．05；(835±190) ng/L vs.(1376±301) ng/L，P<0.05］。结论： 在最优药物治疗基础上，IABP能进一步降低晚期DCM患者BNP值。
Abstract:
AIM:To evaluate the efficacy and the safety of intra-aortic balloon pump (IABP) counterpulsation and its effect on the concentration of serum brain natriuretic peptide (BNP) in patients with terminal dilated cardiomyopathy (DCM). METHODS: Forty-one patients with DCM complicated by pump failure were divided into IABP group (A: 21 cases) and control group (B: 20 cases) based upon the optimal medication. The plasma concentration of BNP was measured using chemiluminescence immunoassay at 1, 2 and 7 days after admission. RESULTS: On the first day of admission, no statistical difference in the values of BNP concentration was observed between groups. On the second and the seventh day of admission, the values of BNP concentration in group A were lower than those in group B (1778±289) pg/ml vs. (2553±346) pg/ml, P<0.05; (835±190) pg/ml vs. (1376±301) pg/ml, P<0.05). CONCLUSION: In patients with terminal DCM complicated with pump failure, IABP counterpulsation based upon the optimal medication is an effective and safe method to improve cardiac function and lower plasma BNP level.

参考文献/References

[1]廖玉华,王朝晖,涂源淑,等.扩张型心肌病的分期及其临床意义[J].临床心血管病杂志,2000,16(3):110-112.
[2]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690.
[3]全国心肌炎、心肌病专题研讨会组委会.全国心肌炎、心肌病专题研讨会纪要[J].临床心血管病杂志,1995,11(6):324-326.
[4]李伟,李成祥,贾国良,等.主动脉球囊反搏治疗急性心肌梗死引起的心力衰竭[J].心脏杂志,2001,13(5):417-417.
[5]Goyal D,Nadar SK,Wrigley B,et al.Successful use of intra-aortic counter pulsation therapy for intractable ventricular arrhythmia in patient with severe left ventricular dysfunction and normal coronary arteries[J].Cardiol J,2010,17(4):401-403.
[6]Moreno R,Garcia E,Abeytua M,et al.Early coronary angioplasty for acute myocardial infarction complicated by cardiogenic shock：have novel therapies led to better results[J].J Invasive Cardiol,2000,12(12):597-604.
[7]Mehra MR,Maisd A.B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use[J].Crit Pathol Cardiol,2005,4(1):10-20.
[8]缪克强,王建安.左室功能不全患者血清脑钠尿肽的水平及诊断价值[J].心脏杂志,2004,16(6):562-563,566.
[9]张政.扩张型心肌病患者心功能与血清B型利钠肽浓度的关系[J].临床心血管病杂志,2009,25(1):18-19.

备注/Memo

备注/Memo:
收稿日期：2012-04-10.作者简介：冯春光，副主任医师，硕士 Email:fcg999@163.com
更新日期/Last Update: 2012-12-30